cbdMD, Inc.
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 13, 2026
YCBD$0.38-8.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 6. Exhibits
| Incorporated by Reference · Filed or Furnished | ||||
|---|---|---|---|---|
| No. · Exhibit Description · Form · Date Filed · Number · Herewith | ||||
| 2.1 | Merger Agreement dated December 3, 2018 by and among Level Brands, Inc., AcqCo, LLC, cbdMD LLC and Cure Based Development, LLC | 8-K | 12/3/18 | 2.1 |
| 2.2 | Articles of Merger dated December 20, 2018 as filed with the Secretary of State of Nevada merging AcqCo, LLC with and into Cure Based Development, LLC | 10-Q | 2/14/19 | 2.2 |
| 2.3 | Articles of Merger dated December 20, 2018 as filed with the Secretary of State of North Carolina merging AcqCo, LLC with and into Cure Based Development, LLC | 10-Q | 2/14/19 | 2.3 |
| 2.4 | Articles of Merger dated December 20, 2018 as filed with the Secretary of State of Nevada merging Cure Based Development, LLC with an into cbdMD LLC | 10-Q | 2/14/19 | 2.4 |
| 2.5 | Articles of Merger dated December 20, 2018 as filed with the Secretary of State of North Carolina merging Cure Based Development, LLC with an into cbdMD LLC | 10-Q | 2/14/19 | 2.5 |
| 2.6 | Addendum No. 1 to Agreement and Plan of Merger dated March 31, 2021 | 8-K | 4/1/21 | 10.1 |
| 3.1 | Articles of Incorporation | 1-A | 9/18/17 | 2.1 |
| 3.2 | Articles of Amendment to the Articles of Incorporation – filed April 22, 2015 | 1-A | 9/18/17 | 2.2 |
| 3.3 | Articles of Amendment to the Articles of Incorporation – filed June 22, 2015 | 1-A | 9/18/17 | 2.3 |
| 3.4 | Articles of Amendment to the Articles of Incorporation – filed November 17, 2016 | 1-A | 9/18/17 | 2.4 |
| 3.5 | Articles of Amendment to the Articles of Incorporation – filed December 5, 2016 | 1-A | 9/18/17 | 2.5 |
| 3.6 | Articles of Amendment to Articles of Incorporation | 8-K | 4/29/19 | 3.7 |
| 3.7 | Articles of Amendment to the Articles of Incorporation including the Certificate of Designations, Rights and Preferences of the 8.0% Series A Cumulative Convertible Preferred Stock | 8-A | 10/11/19 | 3.1(f) |
| 3.8 | Articles of Amendment of Articles of Incorporation, as amended, of cbdMD, Inc. effective April 24, 2023 - reverse stock split | 8-K | 4/27/23 | 3.1 |
| 3.9 | Articles of Amendment Automatic Conversion of Preferred Stock effective May 6, 2025 | 8-K | 5/7/25 | 3.1 |
| 3.10 | Articles of Amendment to the Articles of Incorporation 8 to 1 reverse split effective May 6, 2025 | 8-K | 5/7/25 | 3.2 |
| 3.11 | Certificate of Designation of Series B Convertible Preferred Stock filed September 29, 2025 | 8-K | 10/6/25 | 3.1 |
| 3.12 | Certificate of Designation of Series C Convertible Preferred Stock filed December 19, 2025 | 10-K | 12/19/25 | 3.12 |
| 3.13 | Bylaws, As amended | 1-A | 9/18/17 | 2.6 |
| 10.1 | Form of Preferred Stock Purchase Agreement between cbdMD, Inc. and the Selling Shareholders+ | 8-K | 10/6/25 | 10.1 | |
| 10.2 | Form of Registration Rights Agreement between cbdMD, Inc. and the Selling Shareholders | 8-K | 10/6/25 | 10.2 | |
| 10.3 | Executive Employment Agreement dated November 28, 2025 by and between cbdMD, Inc. and T. Ronan Kennedy++ | 8-K | 11/28/25 | 10.1 | |
| 10.4 | 2025 Equity Compensation Plan++ | 8-K | 11/28/25 | 10.2 | |
| 10.5 | Registration Rights Agreement by and between cbdMD, Inc. and C/M Capital Master Fund, LP, dated December 15, 2025 | 10-K | 12/19/25 | 10.21 | |
| 10.6 | Form of Series C Preferred Stock Securities Purchase Agreement dated December 19, 2025 | 10-K | 12/19/25 | 10.22 | |
| 10.7 | Form of Registration Rights Agreement dated December 19, 2025 | 10-K | 12/19/25 | 10.23 | |
| 10.8 | Securities Purchase Agreement by and between cbdMD, Inc. and C/M Capital Master Fund, LP, dated December 15, 2025, as amended | S-1 | 1/5/26 | 10.20 | |
| 10.9 | Asset Purchase Agreement by and among cbdMD, Inc., Gaia Botanicals, LLC d/b/a Bluebird Botanicals, CBD CliniLabs LLC and Precision Botanical LLC company dated January 12, 2026+ | 8-K | 1/14/26 | 10.1 | |
| 10.10 | Lockup Agreement Gaia Botanicals, LLC and cbdMD, Inc., dated January 12, 2026 | 8-K | 1/14/26 | 10.2 | |
| 10.11 | Letter Agreement between cbdMD, Inc. and Series C Preferred Shareholders dated February 10, 2026 | 10-Q | 2/17/26 | 10.11 | |
| 10.12 | Third Amendment to Lease effective May 20, 2026 | 8-K | 5/20/26 | 10.1 | |
| 31.1 | Certification of Principal Executive Officer and Principal Financial Officer (Section 302) | Filed | |||
| 32.1 | Certification of Principal Executive Officer and Principal Financial Officer (Section 906) | Furnished* | |||
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | Filed | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | Filed | |||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | Filed | |||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | Filed | |||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | Filed | |||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | Filed | |||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL Document and include in Exhibit 101) | Filed | |||
- Certain exhibits, appendices and/or schedules have been omitted in accordance with Item 601 of Regulation S-K. The Company hereby agrees to furnish to the staff of the Securities and Exchange Commission upon request any omitted information.
++ Management contract of compensatory plan or arrangement.
- This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.
Copies of this report (including the financial statements) and any of the exhibits referred to above will be furnished at no cost to our stockholders who make a written request to our Corporate Secretary at cbdMD, Inc. 2101 Westinghouse Blvd, Suite A, Charlotte, NC 28273.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by a duly authorized officer of the registrant and by the principal financial or chief accounting officer of the registrant.
| cbdMD, INC. | ||
| August 13, 2026 | By: | /s/ T. Ronan Kennedy |
|---|---|---|
| T. Ronan Kennedy Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) | ||
| August 13, 2026 | By: | /s/ Brad Whitford |
| Brad Whitford, Chief Accounting Officer | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.